Amgen reported $4.12B in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
ALKERMES ALKS:US $ 136.08M 1.9M
Amgen AMGN:US $ 4115M 98M
Biogen BIIB:US $ 1254.8M 83M
Biomarin Pharmaceutical BMRN:US $ 710.98M 2.95M
Bluebird Bio BLUE:US $ 13.5M 4.58M
Bristol Myers Squibb BMY:US $ 2137M 184M
Coherus Biosciences CHRS:US $ 96.08M 44.47M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Exelixis EXEL:US $ 24.98M 0.22M
Gilead Sciences GILD:US $ 2988M 8M
GlaxoSmithKline GSK:LN 6330M 114M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Johnson & Johnson JNJ:US $ 10100M 148M
Neurocrine Biosciences NBIX:US $ 28.3M 1.8M
Novartis NOVN:VX SF 7111M 114M
Ptc Therapeutics PTCT:US $ 16.44M 0.21M
Puma Biotechnology PBYI:US $ 7.62M 0.12M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
Teva Pharmaceutical TEVA:IT 4.36B 44M
Ultragenyx Pharmaceutical RARE:US $ 15.08M 2.62M
Vertex Pharmaceuticals VRTX:US $ 321.62M 22.76M
YTE INCY:US $ 16.68M 0.02M